Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| fibroblast | 16 studies | 42% ± 16% | |
| connective tissue cell | 9 studies | 54% ± 21% | |
| endothelial cell of lymphatic vessel | 8 studies | 31% ± 22% | |
| myofibroblast cell | 7 studies | 58% ± 26% | |
| pericyte | 7 studies | 35% ± 17% | |
| mesothelial cell | 6 studies | 57% ± 21% | |
| smooth muscle cell | 5 studies | 61% ± 16% | |
| basal cell | 4 studies | 31% ± 16% | |
| epithelial cell | 4 studies | 50% ± 24% | |
| endothelial cell | 4 studies | 29% ± 14% | |
| progenitor cell | 3 studies | 49% ± 22% | |
| extravillous trophoblast | 3 studies | 32% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| ovary | 100% | 1660.73 | 180 / 180 | 88% | 82.15 | 379 / 430 |
| breast | 99% | 999.78 | 455 / 459 | 88% | 38.98 | 985 / 1118 |
| uterus | 100% | 2456.86 | 170 / 170 | 82% | 69.44 | 375 / 459 |
| lung | 99% | 883.92 | 570 / 578 | 82% | 33.27 | 951 / 1155 |
| pancreas | 89% | 454.13 | 292 / 328 | 88% | 43.87 | 156 / 178 |
| bladder | 100% | 854.05 | 21 / 21 | 76% | 34.99 | 384 / 504 |
| skin | 99% | 1490.81 | 1788 / 1809 | 67% | 29.67 | 316 / 472 |
| intestine | 87% | 558.09 | 843 / 966 | 62% | 17.48 | 326 / 527 |
| thymus | 92% | 447.20 | 599 / 653 | 57% | 12.70 | 346 / 605 |
| esophagus | 77% | 440.86 | 1118 / 1445 | 60% | 20.47 | 110 / 183 |
| prostate | 99% | 921.04 | 243 / 245 | 21% | 2.76 | 103 / 502 |
| stomach | 48% | 257.71 | 172 / 359 | 67% | 20.24 | 192 / 286 |
| eye | 0% | 0 | 0 / 0 | 100% | 76.14 | 80 / 80 |
| ureter | 0% | 0 | 0 / 0 | 100% | 38.09 | 1 / 1 |
| blood vessel | 100% | 1738.88 | 1333 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 99% | 1323.25 | 1197 / 1204 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 71% | 26.69 | 32 / 45 |
| heart | 58% | 280.33 | 498 / 861 | 0% | 0 | 0 / 0 |
| adrenal gland | 26% | 73.89 | 67 / 258 | 17% | 3.24 | 40 / 230 |
| kidney | 36% | 183.93 | 32 / 89 | 6% | 1.99 | 58 / 901 |
| spleen | 15% | 38.77 | 35 / 241 | 0% | 0 | 0 / 0 |
| liver | 2% | 5.54 | 5 / 226 | 9% | 2.04 | 36 / 406 |
| brain | 0% | 0.44 | 5 / 2642 | 9% | 3.35 | 65 / 705 |
| muscle | 8% | 27.13 | 63 / 803 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 7% | 0.97 | 2 / 29 |
| peripheral blood | 0% | 0.53 | 2 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0048050 | Biological process | post-embryonic eye morphogenesis |
| GO_0048048 | Biological process | embryonic eye morphogenesis |
| GO_0030220 | Biological process | platelet formation |
| GO_0120162 | Biological process | positive regulation of cold-induced thermogenesis |
| GO_0001527 | Cellular component | microfibril |
| GO_0005576 | Cellular component | extracellular region |
| GO_0062023 | Cellular component | collagen-containing extracellular matrix |
| GO_0005201 | Molecular function | extracellular matrix structural constituent |
| GO_0070051 | Molecular function | fibrinogen binding |
| GO_0001968 | Molecular function | fibronectin binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | MFAP2 |
| Protein name | Microfibrillar-associated protein 2 (MFAP-2) (Microfibril-associated glycoprotein 1) (MAGP) (MAGP-1) |
| Synonyms | MAGP1 |
| Description | FUNCTION: Component of the elastin-associated microfibrils. |
| Accessions | ENST00000375534.7 [P55001-2] P55001 ENST00000375535.4 [P55001-1] |